Grufity logo
Grufity logo

Latest Cormorant Asset Management, LP Stock Portfolio

$1.99Billion | No. of Holdings #46

Cormorant Asset Management, LP Performance

2026 Q1-1.13%
YTD-1.13%
2025+40.04%

About Cormorant Asset Management, LP and 13F Hedge Fund Stock Holdings

Cormorant Asset Management, LP is a hedge fund based in Boston, MA. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Cormorant Asset Management, LP reported an equity portfolio of $2 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Cormorant Asset Management, LP are PRAX, , EYPT. The fund has invested 14.3% of it's portfolio in PRAXIS PRECISION MEDICINES I and 8% of portfolio in BRIDGEBIO ONCOLOGY THERAPEUT. <br><br> The fund managers got completely rid off ENGENE HOLDINGS INC, GH RESEARCH PLC (GHRS) and JANUX THERAPEUTICS INC (JANX) stocks. They significantly reduced their stock positions in ABIVAX SA, AXSOME THERAPEUTICS INC. (AXSM) and INSMED INC (INSM). Cormorant Asset Management, LP opened new stock positions in ERASCA INC (ERAS), DIANTHUS THERAPEUTICS INC and DAMORA THERAPEUTICS INC (GLTO). The fund showed a lot of confidence in some stocks as they added substantially to BIOHAVEN LTD, OLEMA PHARMACEUTICALS INC (OLMA) and CABALETTA BIO INC (CABA).
Cormorant Asset Management, LP Equity Portfolio Value
Last Reported on: 15 May, 2026
$1.99Billion
  as of May 15, 2026

Cormorant Asset Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Cormorant Asset Management, LP made a return of -1.13% in the last quarter. In trailing 12 months, it's portfolio return was 78.61%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
erasca inc93,844,000
dianthus therapeutics inc79,724,000
damora therapeutics inc39,497,500
tango therapeutics inc29,811,000
agomab therapeutics nv25,861,500
maze therapeutics inc22,387,500
roivant sciences ltd20,775,000
adlai nortye ltd20,053,200
New stocks bought by Cormorant Asset Management, LP

Additions

Ticker% Inc.
biohaven ltd17,500
olema pharmaceuticals inc41.82
bioage labs inc41.65
cabaletta bio inc25.00
alumis inc8.63
moonlake immunotherapeutics2.87
Additions to existing portfolio by Cormorant Asset Management, LP

Reductions

Ticker% Reduced
abivax sa-43.7
axsome therapeutics inc.-33.33
insmed inc-30.91
bridgebio pharma inc-29.17
centessa pharmaceuticals plc-20.75
vaxcyte inc-20.00
crinetics pharmaceuticals in-16.67
amylyx pharmaceuticals inc-12.5
Cormorant Asset Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
engene holdings inc-36,120,000
gh research plc-16,510,000
janux therapeutics inc-8,970,000
Cormorant Asset Management, LP got rid off the above stocks

Sector Distribution

Cormorant Asset Management, LP has about 55.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare55.4
Others44.6

Market Cap. Distribution

Cormorant Asset Management, LP has about 5.8% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • LARGE-CAP
  • NANO-CAP
  • MICRO-CAP
Category%
UNALLOCATED44.6
MID-CAP30.4
SMALL-CAP14.6
LARGE-CAP5.8
NANO-CAP2.7
MICRO-CAP1.9

Stocks belong to which Index?

About 30% of the stocks held by Cormorant Asset Management, LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others70
RUSSELL 200030
Top 5 Winners (%)%
alumis inc
115.0 %
oruka therapeutics inc
61.8 %
CNTA
centessa pharmaceuticals plc
52.7 %
MLTX
moonlake immunotherapeutics
40.6 %
EWTX
edgewise therapeutics inc
26.8 %
Top 5 Winners ($)$
alumis inc
46.5 M
PRAX
praxis precision medicines i
25.2 M
MLTX
moonlake immunotherapeutics
24.1 M
EWTX
edgewise therapeutics inc
21.9 M
CNTA
centessa pharmaceuticals plc
17.5 M
Top 5 Losers (%)%
OLMA
olema pharmaceuticals inc
-36.6 %
EYPT
eyepoint inc
-29.4 %
bridgebio oncology therapeut
-28.5 %
CRNX
crinetics pharmaceuticals in
-20.1 %
ARQT
arcutis biotherapeutics inc
-17.9 %
Top 5 Losers ($)$
bridgebio oncology therapeut
-63.8 M
EYPT
eyepoint inc
-44.5 M
OLMA
olema pharmaceuticals inc
-33.5 M
abivax sa
-24.8 M
DRUG
bright minds biosciences inc
-5.4 M

Cormorant Asset Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Cormorant Asset Management, LP

Cormorant Asset Management, LP has 46 stocks in it's portfolio. About 59.1% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Cormorant Asset Management, LP last quarter.

$1.98BTotal Value
49.00Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of Cormorant Asset Management, LP, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Cormorant Asset Management, LP's holding in Ascendis Pharma A/S over time
1.09%95,000
$21.73M
1.09%
decreased 5 percentreduced
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Cormorant Asset Management, LP's holding in Bright Minds Biosciences Inc over time
3.88%1,059,330
$77.30M
3.88%
unchanged 0 percentunchanged
GHRS
Gh Research Plc

Gh Research Plc

GHRS
Cormorant Asset Management, LP's holding in Gh Research Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off